Early in the history of endoprosthetic hip and knee joint replacements almost exclusively had cement fixations. Now the objective is to replace only the areas of joints actually affected by arthritis and which cause a patient pain.
Visual interfaces facilitate natural and simple interfaces for human-robot interaction. Nowadays there are many applications using these, such as teleconferencing with improved visual sensation, virtual reality systems, lip readers, assistance for mobility assistance for the disabled, etc. The use of head movements and gestures offers a natural way for severely disabled people, who cannot use a…
Prostate cancer, the most common neoplasm in men, often progresses from an androgen-dependant state (and is commonly treated by androgen ablation therapies) to a hormone-refractory stage, therefore making hormone therapy ineffective. The response duration to androgen ablation therapy is finite and ultimately most prostate cancer will become hormone-insensitive.
Christopher Pryce, PhD, describes a promising test that can predict the onset of Alzheimer's disease some two years earlier than currently available tests can determine. Furthermore, the test can be used in non-human primates in order to research the neurobiology and pharmacology of such neurodegenerative illnesses. Dr. Pryce is conducting preclinical research with this test together with…
Professor Wolfgang Schlegel, Head of the Department of Medical Physics at the German Cancer Research Centre, has been awarded the 2003 clinical section of the German Cancer Award, for significantly improving the precision with which radiation beams can be directed at a tumour.
More than 80 billion neurons, trillions of synapses and almost 6 kilometres of neural pathways: The brain is an anatomical masterpiece – and still puzzles science. Keep reading to find out about latest research and therapies of brain diseases.
Many different forms, unclear origins: Multiple sclerosis (MS) is one of the most common neurological diseases that often leads to disability in those affected. Read more about current research and therapeutic approaches to MS.